Inside The J.P. Morgan Healthcare Extravaganza

In this week’s edition of InnovationRx, we look at a ‘holy grail’ pill for sleep apnea, Pomelo Care’s expansion, Nvidia and Lilly’s $1 billion AI venture, and more.

Brightline Hires Ex-Eurostar Chief As Vegas Bullet Train Costs Climb

Nicolas Petrovic, who led the London-Paris-Brussels train systems, will oversee the company’s expanding Florida operations and the first U.S. high-speed railway.

This $500 Million AI Startup Runs Customer Interviews For Microsoft And Sweetgreen

The San Francisco-based company, which has run more than 1 million customer interviews with its automated AI tools to help major companies figure out what their users want, has now raised $69 million.

Honor Win Is A Phone With A 10,000 mAh Battery And A Built-In Fan

The Honor Win also packs an AMOLED display with 185Hz refresh rate, all for about $500 — but it’s only selling in China.

AI Fraud Has Exploded. This Background-Check Startup Is Cashing In.

San Francisco-based Checkr has seen its revenues jump 14% to $800 million as companies try to spot a flood of AI-generated CVs and faked financial documents.

The Safest Airlines In The World, Rated In A 2026 Report

A new report from AirlineRatings.com ranks the safest airlines in the world, along with the safest low-cost airlines, and explains why the margins are tighter than ever.

The U.S. Goes Rogue On The Climate Fight

This week’s Current Climate newsletter also looks at the AI boom’s water problem and stabilized funding for the California High-Speed Rail project.

Thai Billionaire Harald Link’s B.Grimm Power Buys $230 Million Stake In U.S. Hydropower Operator

B.Grimm Power—controlled by Thai billionaire Harald Link—has bought a stake in U.S.-based hydropower operator New England Reliable Hydropower Holdings for 7.24 billion baht ($230 million) amid the group’s drive to expand its overseas renewable energy p…

A ‘Holy Grail’ Sleep Apnea Pill Could Be On The Market Next Year

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

AI 50 2026: Submissions For Forbes’ List Of The Top 50 AI Startups Is Open

Forbes’ eighth annual AI 50 list, featuring the most prominent AI startups, is accepting submissions until February 6, 2026.